Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
09.06.25
/
50%
€29.00
Target price
09.06.26
€46.41
Performance (%)
76.00%
Price
29.04.26
€51.04
Summary
This prediction is currently active. With a performance of 76.00% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 09.06.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -9.887% | -9.887% |
| iShares Core DAX® | -1.499% | 7.705% |
| iShares Nasdaq 100 | 1.380% | 16.275% |
| iShares Nikkei 225® | -1.992% | 13.113% |
| iShares S&P 500 | 0.345% | 10.816% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JPMorgan Chase & Co. from $71.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
17.03.26
17.03.26
€65.24
17.03.27
17.03.27
-5.48%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
20.01.26
20.01.26
€63.57
20.01.27
20.01.27
-5.48%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25